| Product Name | NebuSelect™ Recombinant Human Coagulation factor XI, His-tag |
|---|---|
| Catalog Number | NBL-242615 |
| Alias/Synonyms | Coagulation factor XI; Coagulation factor XI; FXI; PTA; F11 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P03951-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242615-100ug | 100ug | Inquire | Inquire | |
| NBL-242615-1mg | 1mg | Inquire | Inquire | |
| NBL-242615-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Coagulation factor XI, His-tag
Catalog#:
NBL-242615
Description:
NebuSelect™ Recombinant Human Coagulation factor XI, His-tag(Cat#NBL-242615) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu19-Val625.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 69.1 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Target Name:
Coagulation factor XI; Coagulation factor XI; FXI; PTA; F11
Target Information:
Coagulation factor (F)XI has been described as a component of the early phase of the contact pathway of blood coagulation, acting downstream of factor XII.In contrast to its mild hemostatic activities, FXI is known to play a significant role in thrombosis, as it is a demonstrated independent risk factor for deep vein thrombosis, ischemic stroke, and myocardial infarction. A better understanding of the varied and complex role of FXI in both thrombosis and hemostasis will help to allow better prediction of bleeding risk in FXI-deficient patients and also informing the development of targeted agents to inhibit the thrombotic activities of FXI while preserving hemostasis.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.